RainDance Technologies, a Lexington, MA-based provider of life sciences research products, has raised $6 million of a $12 million round of private equity financing, according to an SEC filing. It’s unclear from the document who invested in the financing, but the firm lists its previous investors on its website. RainDance says its flagship product is the “RDT 1000” system, which applies its microdroplet-based technology to accelerate “targeted sequencing regions of the human genome.”
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
